For citations:
Lubennikova EV, Vishnevskaya YV. Role of Post-Neoadjuvant therapy with trastuzumab emtansine in HER2-positive breast cancer. Meditsinskiy sovet = Medical Council. 2021;(20):68-74. (In Russ.) https://doi.org/10.21518/2079-701X-2021-20-68-74